CompletedNCT03324581
What is this study about?This study evaluated the safety and effectiveness of OPC-64005 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Beverly HillsADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
TerminatedNCT05067322
Official study titleTherapeutic Gaming for the Treatment of Attention Deficit Hyperactivity Disorder
This study ended early.
Location not clearly listedADHDDevice studyAges 10–15
- Countries
- Sponsor
- Spherix Incorporated
CompletedNCT00510276
What is this study about?Researchers compared Atomoxetine hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesADHDMedication studyAges 18–30
- Countries
- United States
- Sponsor
- Eli Lilly and Company
WithdrawnNCT00931398
What is this study about?Researchers are comparing methylphenidate HCl (Concerta) and placebo to find out how the approaches affect ADHD symptoms in people with ADHD.
This study was withdrawn before enrollment.
In PittsburghADHDMedication studyAges 18–25
- Countries
- United States
- Sponsor
- University of Pittsburgh
CompletedNCT00191048
Official study titleOpen-Label Treatment With Atomoxetine Hydrochloride in Child and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia
This study has finished and is no longer accepting participants.
Multiple locations, including Rolling Hills EstateADHDMedication studyAges 10–16
- Countries
- United States
- Sponsor
- Eli Lilly and Company
RecruitingNCT05935722
About this title
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
Read the official source — NCT05935722Official study titleEvaluation of a Home-based Parenting Support Program - Parenting Young Children - for Parents With Intellectual and Developmental Disabilities When There is a Risk for Neglect
Multiple locations, including EnköpingADHDBehavioural study
- Countries
- Sweden
- Sponsor
- Örebro University, Sweden
CompletedEUCTR 2005-005330-12
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomADHDHistorical research recordAges 12–17
- Countries
- United Kingdom
- Sponsor
- King's College London (IOP)
CompletedNCT01174355
What is this study about?This study evaluated the safety and effectiveness of ND0801 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including HaifaADHDMedication studyAges 18–55
- Countries
- Israel
- Sponsor
- NeuroDerm Ltd.
CompletedNCT02986672
Official study titleADHD and Nutrition: The Influence of Omega-3 on ADHD Related Symptoms
This study has finished and is no longer accepting participants.
Multiple locations, including KarasjokADHDPlacebo comparisonAges 6–16
- Countries
- Norway
- Sponsor
- University Hospital of North Norway
UnknownNCT02167048
Official study titleEffects of Low-dose Versus Normal-dose Psychostimulants on Executive Functions in Individuals With Attention-Deficit Hyperactivity Disorder
Current recruitment status is unconfirmed.
In VancouverADHDMedication studyAges 6–18
- Countries
- Canada
- Sponsor
- University of British Columbia
CompletedNCT06491836
Official study titleThe Effect of an Oligoantigenic Diet on Core Symptomatology of Children With Attention-Deficit /Hyperactivity Disorder (ADHD).
This study has finished and is no longer accepting participants.
In CairoADHDInterventional studyAges 6–16
- Countries
- Egypt
- Sponsor
- Ain Shams University
RecruitingACTRN12615000296538
Official study titleIn children and adolescents, is assessment of ADHD using the novel "EfA system" as effective and sensitive as other known methods in reaching a high quality and accurate diagnosis?
In New ZealandADHDInterventional studyAges 6–18
- Countries
- New Zealand
- Sponsor
- Dr. Yariv Doron